FDA Inspection 946004 — Glaxo Wellcome S.A.
The FDA completed an inspection of Glaxo Wellcome S.A. on Sep 25, 2015 in Aranda De Duero. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 25, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aranda De Duero (Spain)